Getting paid: New pre-auth, non-coverage policies may be in your future for HA injections
If you’ve been hit recently with new private payer policies that limit — and in some cases halt — coverage of hyaluronic acid injections (e.g., Orthovisc), you’re not alone. Practices around the country report that their payers are tightening their policies for the joint therapy.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.